Search for: "NOVARTIS PHARMACEUTICALS CORP."
Results 321 - 340
of 367
Sorted by Relevance
|
Sort by Date
7 May 2009, 6:08 am
Novartis Pharmaceuticals Corp., 252 F.3d 986, 990 (8th Cir. 2001); Hans v. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
5 Jan 2011, 9:22 am
Novartis Pharmaceuticals Corp., Case No. 04-CV-9194 (S.D.N.Y.) following a seven-week trial in the Spring of 2010. [read post]
11 Sep 2012, 11:36 am
Novartis Pharmaceutical Corp. [read post]
22 Feb 2008, 6:00 pm
., and AT&T Corp. v. [read post]
21 Dec 2012, 11:41 am
Mutual Pharmaceutical Co., 678 F.3d 30 (1st Cir. 2012). [read post]
26 May 2015, 7:42 am
Claims such as in Mills, which are at loggerheads with FDA criteria for drug development, are precisely those with the most potential for making pharmaceutical manufacturers into “sitting ducks” for litigation, in this instance litigation based on extraneous genetic factors.It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
24 Dec 2009, 11:32 am
AstraZeneca Pharmaceuticals, L.P., ___ S.W.3d ___, 2009 WL 3681868 (Ark. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
17 Oct 2015, 5:29 am
Novartis Pharms., No. 5:11–CV–680–D, 2013 WL 4854488, at *3 (Sept. 11, 2013). [read post]
5 Jun 2013, 5:29 am
Everest Minerals Corp., 362 F. [read post]
16 Nov 2009, 4:51 am
Corp. [read post]
16 Nov 2009, 4:51 am
Corp. [read post]
16 Nov 2009, 4:51 am
Corp. [read post]
28 Oct 2011, 7:00 am
Mentor Corp., 15 Fed. [read post]
22 May 2014, 5:00 am
We were recently asked if we had anything on the blog about taking depositions of active FDA personnel – active as opposed to former (many of whom are available to be hired as litigation “experts”). [read post]
10 Apr 2013, 1:42 pm
Novartis Pharmaceuticals Corp. [read post]
